Ron Seubert

Ron Seubert is the founder, President, and CEO of RareCyte. Previously Ron was co-founder of both Applied Precision LLC and Applied Precision Inc. (API). Over a period of 20 years as President and CEO, Ron led these companies through consistent and rapid growth by developing innovative products in both the life sciences and semi-conductor industries. Most notably, API developed the DeltaVision microscopy line of products that led the way in live cell and high resolution microscopy as well as an OEM business that built technologies for companies like Becton Dickinson (NYSE: BDX). In 2011, API was sold to GE Healthcare and RareCyte was spun-out with an equity investment from Telegraph Hill Partners and management.